创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

纪晓霞, 刘红霞, 何朝勇. PDGF/PDGFR信号通路在纤维化疾病中的作用研究进展[J]. 药学进展, 2022, 46(2): 153-160.
引用本文: 纪晓霞, 刘红霞, 何朝勇. PDGF/PDGFR信号通路在纤维化疾病中的作用研究进展[J]. 药学进展, 2022, 46(2): 153-160.
JI Xiaoxia, LIU Hongxia, HE Chaoyong. Progress of Research on the Role of PDGF/PDGFR Signaling Pathway in Fibrotic Diseases[J]. Progress in Pharmaceutical Sciences, 2022, 46(2): 153-160.
Citation: JI Xiaoxia, LIU Hongxia, HE Chaoyong. Progress of Research on the Role of PDGF/PDGFR Signaling Pathway in Fibrotic Diseases[J]. Progress in Pharmaceutical Sciences, 2022, 46(2): 153-160.

PDGF/PDGFR信号通路在纤维化疾病中的作用研究进展

Progress of Research on the Role of PDGF/PDGFR Signaling Pathway in Fibrotic Diseases

  • 摘要: 纤维化是机体受到有害因子刺激造成的成纤维细胞过度激活导致的细胞外基质过度沉积。血小板衍生生长因子(PDGF)是纤维化疾病重要介质之一,PDGF/PDGFR通路参与调控心、肝、肾和皮肤等多器官纤维化。综述PDGF/PDGFR信号通路在纤维化疾病中的作用研究进展,以期为纤维化疾病的治疗提供参考。

     

    Abstract: Fibrosis is the excessive deposition of extracellular matrix caused by excessive activation of fibroblasts stimulated by harmful factors. PDGF is one of the important mediators of fibrotic diseases, and activation of PDGF/PDGFR pathway is involved in the regulation of fibrosis of multiple organs such as heart, liver, kidney and skin. This paper reviews the research progress of PDGF/PDGFR signaling pathway in fibrotic diseases in order to provide reference for the treatment of fibrotic diseases.

     

/

返回文章
返回